Questions and Answers – DBS Therapy
Dystonia
- What is Medtronic Deep Brain Stimulation (DBS) Therapy?
- How does the treatment work?
- What are the implanted components of the Medtronic DBS system?
- Is it possible to adjust the device settings?
- What probable benefits does DBS offer?
- What are the risks of DBS?
- What is the history of DBS?
- What is a Humanitarian Use Device?
What are the implanted components of the Medtronic DBS system?
One neurostimulator is needed for treatment of dystonia. The implanted components are:
- One or two wires (leads) implanted in the brain
- One or two extensions. Your surgeon will connect the leads to the neurostimulator using extensions that run under the skin from the chest to your neck and head
- One neurostimulator, usually implanted beneath the skin in the chest below the collarbone and connected to the extensions (depending on the patient, a surgeon may implant the neurostimulator in the abdomen)
What are the risks of DBS?
Risks of DBS can include risks of surgery, side effects, or device complications. Please refer to Risks and Probable Benefits for more information.
What is the history of DBS?
Neurologists and neurosurgeons have used electrical stimulation since the 1960s as a way to locate and distinguish specific sites in the brain. Medtronic developed brain stimulation technology in the 1980s in conjunction with leading international physician researchers.
Medtronic DBS Therapy is currently approved to treat Parkinson's disease and essential tremor, and as a Humanitarian Device to treat dystonia, epilepsy and obsessive-compulsive disorder. Since 1997, more than 135,000 patients worldwide have received Medtronic DBS Therapy.
What is a Humanitarian Use Device?
The Food and Drug Administration (FDA) approved Medtronic DBS Therapy in 2003 as a Humanitarian Use Device. A Humanitarian Use Device is intended to benefit patients by treating or diagnosing a disease or condition that affects fewer than 4,000 new people in the United States each year.
The FDA reviewed the safety of Medtronic DBS Therapy for dystonia and determined that the probable health benefits outweigh the risks of injury or illness from its use. Efficacy of treatment (effectiveness) has not been established by large clinical trials. Surgery to implant the system can only be performed in a medical center whose institutional review board has approved use of the device.
Referenced path does not exist
Referenced path does not exist